This article was originally published in The Gray Sheet
Board of directors declares a dividend distribution of one common stock purchase right for each outstanding share of Tokos common stock. The rights, which the firm will issue on April 19, may be exercised if any person or group acquires or announces a tender offer for at least 20% of Tokos stock. Each right entitles the bearer to purchase newly issued shares that are worth twice the right's exercise price, which is $30. The board may redeem the rights for one cent each at any time before the tenth day following an entity's acquisition of 20% or more of the common stock. Tokos says that the rights, which expire in 10 years, "are not being distributed in response to any specific effort to acquire control of the company".
You may also be interested in...
Informa Pharma Intelligence has officially launched the seventh Global Generics & Biosimilars Awards, which will take place in October 2020 in Milan, Italy.
Hours before the US FDA confirmed the first drug shortage due to active pharmaceutical ingredient constraints because of the coronavirus situation in China, generics industry leader Mylan came under pressure about the potential impact on its business.
Government advisory committee gives initial nod to what will become Japan’s most expensive single drug, but reimbursement pricing could come in for close scrutiny.